Profile | GDS4284 / 239143_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2349.07 | 86 |
GSM687648 | Patient 402 control | 2277.71 | 85 |
GSM687653 | Patient 403 control | 2573.44 | 87 |
GSM687658 | Patient 404 control | 2163.51 | 85 |
GSM687663 | Patient 411 control | 1435.1 | 79 |
GSM687668 | Patient 422 control | 1712.97 | 82 |
GSM687673 | Patient 424 control | 1496.59 | 80 |
GSM687678 | Patient 425 control | 1742.19 | 82 |
GSM687683 | Patient 427 control | 2063.86 | 84 |
GSM687688 | Patient 428 control | 2279.95 | 86 |
GSM687695 | Patient 441 control | 1034.43 | 76 |
GSM687699 | Patient 443 control | 1847.46 | 83 |
GSM687704 | Patient 444 control | 1877.29 | 83 |
GSM687707 | Patient 448 control | 3163.56 | 89 |
GSM687712 | Patient 449 control | 2386.31 | 86 |
GSM687719 | Patient 450 control | 1548.06 | 80 |
GSM687724 | Patient 451 control | 1666.79 | 82 |
GSM687728 | Patient 452 control | 2029.8 | 84 |
GSM687646 | Patient 401 treated 24h | 3110.76 | 89 |
GSM687649 | Patient 402 treated 24h | 1547.28 | 80 |
GSM687665 | Patient 411 treated 24h | 1873.95 | 83 |
GSM687651 | Patient 402 treated 4 weeks | 1536 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1837.34 | 82 |
GSM687670 | Patient 422 treated 24h | 1774.69 | 82 |
GSM687671 | Patient 422 treated 4 weeks | 1333.63 | 78 |
GSM687654 | Patient 403 treated 24h | 2743.75 | 88 |
GSM687675 | Patient 424 treated 24h | 1917.17 | 83 |
GSM687685 | Patient 427 treated 24h | 1431.19 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 2166.23 | 85 |
GSM687677 | Patient 424 treated 4 weeks | 1559.25 | 80 |
GSM687687 | Patient 427 treated 4 weeks | 1648.62 | 81 |
GSM687692 | Patient 428 treated 4h | 2300.08 | 86 |
GSM687716 | Patient 449 treated 4h | 2207.57 | 85 |
GSM687722 | Patient 450 treated 4h | 2251.46 | 86 |
GSM687680 | Patient 425 treated 24h | 2406.26 | 86 |
GSM687690 | Patient 428 treated 24h | 2637.34 | 87 |
GSM687700 | Patient 443 treated 24h | 1657.76 | 82 |
GSM687705 | Patient 444 treated 24h | 2042.14 | 84 |
GSM687714 | Patient 449 treated 24h | 2356.33 | 86 |
GSM687721 | Patient 450 treated 24h | 1452.6 | 80 |
GSM687682 | Patient 425 treated 4 weeks | 1692.01 | 82 |
GSM687694 | Patient 428 treated 4 weeks | 2010.35 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 2411.12 | 86 |
GSM687718 | Patient 449 treated 4 weeks | 2599.06 | 87 |
GSM687723 | Patient 450 treated 4 weeks | 1695.21 | 82 |
GSM687661 | Patient 404 treated 4h | 2836.43 | 88 |
GSM687710 | Patient 448 treated 4h | 2654.28 | 87 |
GSM687726 | Patient 451 treated 4h | 1790.71 | 83 |
GSM687730 | Patient 452 treated 4h | 1187.14 | 77 |
GSM687660 | Patient 404 treated 24h | 2025.29 | 86 |
GSM687697 | Patient 441 treated 24h | 1953.4 | 84 |
GSM687709 | Patient 448 treated 24h | 3362.38 | 90 |
GSM687725 | Patient 451 treated 24h | 2406.55 | 86 |
GSM687729 | Patient 452 treated 24h | 1974.85 | 85 |
GSM687727 | Patient 451 treated 4 weeks | 1616.44 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 1839.38 | 83 |